Jonathan Chipman

1.1k total citations
51 papers, 739 citations indexed

About

Jonathan Chipman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jonathan Chipman has authored 51 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Jonathan Chipman's work include Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Jonathan Chipman is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Jonathan Chipman collaborates with scholars based in United States, Switzerland and Germany. Jonathan Chipman's co-authors include Martin G. Sanda, Rodney L. Dunn, Peter Chang, Mark S. Litwin, John T. Wei, Meredith M. Regan, Christianne L. Roumie, Carlos G. Grijalva, Marie R. Griffin and Robert A. Greevy and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jonathan Chipman

46 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Chipman United States	15	314	144	93	89	79	51	739
JoAnn Alvarez United States	14	339 1.1×	206 1.4×	65 0.7×	245 2.8×	21 0.3×	29	795
Roland Perfekt Sweden	16	416 1.3×	266 1.8×	210 2.3×	214 2.4×	168 2.1×	29	1.4k
Joann Fontanarosa United States	12	751 2.4×	164 1.1×	55 0.6×	186 2.1×	32 0.4×	30	1.2k
Arti Parekh United States	13	415 1.3×	281 2.0×	39 0.4×	139 1.6×	123 1.6×	19	792
Jennifer Cullen United States	18	741 2.4×	254 1.8×	187 2.0×	130 1.5×	52 0.7×	82	1.3k
Mark Lee United States	15	559 1.8×	131 0.9×	119 1.3×	243 2.7×	67 0.8×	37	1.1k
Christine Engstrom United States	12	411 1.3×	281 2.0×	84 0.9×	52 0.6×	52 0.7×	24	692
Keith J. O’Reilly United States	10	396 1.3×	40 0.3×	116 1.2×	241 2.7×	53 0.7×	15	806
Ronald Kodama Canada	14	661 2.1×	189 1.3×	72 0.8×	279 3.1×	132 1.7×	37	1.1k
Larysa Rydzewska United Kingdom	16	1.0k 3.3×	317 2.2×	138 1.5×	157 1.8×	101 1.3×	33	1.5k

Countries citing papers authored by Jonathan Chipman

Since Specialization

Citations

This map shows the geographic impact of Jonathan Chipman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Chipman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Chipman more than expected).

Fields of papers citing papers by Jonathan Chipman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Chipman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Chipman. The network helps show where Jonathan Chipman may publish in the future.

Co-authorship network of co-authors of Jonathan Chipman

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Chipman. A scholar is included among the top collaborators of Jonathan Chipman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Chipman. Jonathan Chipman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Jennifer, Jonathan Chipman, Peter Jacko, et al.. (2025). Randomization in the age of platform trials: unexplored challenges and some potential solutions. BMC Medical Research Methodology. 25(1). 268–268.

Sanuade, Olutobi Adekunle, Allison J. Carroll, Jiancheng Ye, et al.. (2025). Contextual factors and implementation strategies for a multi-level community-based sodium reduction intervention in Chicago’s South Side: a qualitative study. International Journal of Behavioral Nutrition and Physical Activity. 22(1). 93–93. 1 indexed citations

Coletta, Adriana M., Sarah Taylor, Pamela A. Hansen, et al.. (2024). Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial. BMC Cancer. 24(1). 493–493. 1 indexed citations

Uschner, Diane, Oleksandr Sverdlov, Jonathan Chipman, et al.. (2024). Rejoinder. Statistics in Biopharmaceutical Research. 16(4). 425–427. 1 indexed citations

Chipman, Jonathan, William F. Rosenberger, Oleksandr Sverdlov, & Diane Uschner. (2024). Special Issue on Randomization Methods to Design and Analyze Trial Estimands, Adjust for Covariates, and Implement Efficient Designs. Statistics in Biopharmaceutical Research. 16(4). 403–404.

Jo, Yeonjung, Sonam Puri, Benjamin Haaland, et al.. (2024). Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer. Clinical Lung Cancer. 26(1). 29–38.

Tercyak, Kenneth P., Yizhe Xu, Jonathan Chipman, et al.. (2024). Reducing UVR Exposure in Pregnant Women and Infants: A Pilot Study. Journal of Cancer Education. 40(4). 528–541.

Uschner, Diane, Oleksandr Sverdlov, Jonathan Chipman, et al.. (2023). Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions. Statistics in Biopharmaceutical Research. 16(4). 405–413. 10 indexed citations

Sverdlov, Oleksandr, R.-D Hilgers, Colin Everett, et al.. (2023). Which Randomization Methods Are Used Most Frequently in Clinical Trials? Results of a Survey by the Randomization Working Group. Statistics in Biopharmaceutical Research. 16(4). 441–455. 5 indexed citations

10.

Stump, Tammy K., Yeonjung Jo, Jonathan Chipman, et al.. (2023). Objectively-Assessed Ultraviolet Radiation Exposure and Sunburn Occurrence. International Journal of Environmental Research and Public Health. 20(7). 5234–5234. 3 indexed citations

11.

Jo, Yeonjung, Jonathan Chipman, Benjamin Haaland, et al.. (2022). A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern. JTO Clinical and Research Reports. 3(3). 100280–100280. 14 indexed citations

12.

Berger, Vance W., Jonathan Chipman, Colin Everett, et al.. (2021). A roadmap to using randomization in clinical trials. BMC Medical Research Methodology. 21(1). 168–168. 60 indexed citations

13.

Coletta, Adriana M., Mary C. Playdon, Kelly Glazer Baron, et al.. (2021). The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors. PLoS ONE. 16(10). e0258135–e0258135. 2 indexed citations

14.

Parsons, Matthew, Jonathan Chipman, Lindsay Burt, et al.. (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecologic Oncology. 162(2). 454–460. 5 indexed citations

15.

Swami, Umang, Pedro Isaacsson Velho, Roberto Nussenzveig, et al.. (2020). Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. European Urology. 78(5). 652–656. 52 indexed citations

16.

Kishi, Takayuki, Jonathan Chipman, Khanh Nghiem, et al.. (2019). Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis. The Journal of Rheumatology. 47(7). 1011–1018. 29 indexed citations

17.

Chipman, Jonathan, Martin G. Sanda, Meredith M. Regan, et al.. (2018). Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP. Practical Radiation Oncology. 8(6). 445–451. 2 indexed citations

18.

Min, Jea Young, Jonathan Chipman, Robert A. Greevy, et al.. (2018). Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the veterans health administration. BMJ Open. 8(3). e020455–e020455. 15 indexed citations

19.

Chipman, Jonathan, Martin G. Sanda, Rodney L. Dunn, et al.. (2013). Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical Practice. The Journal of Urology. 191(3). 638–645. 56 indexed citations

20.

Hoppe, Bradford S., Jeff M. Michalski, Nancy P. Mendenhall, et al.. (2013). Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer. Cancer. 120(7). 1076–1082. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact